We are a coalition of doctors, researchers, patients, and entrepreneurs pioneering a new approach to curing diseases through innovative outcome-based financing. We collaborate with impact investors and payers to discover life-altering therapies and bring them to patients.

Our Target is Chronic Pancreatitis

The first disease we are attacking is pancreatitis. The world’s top pancreatic experts believe a well-funded, coordinated research and development program could lead to effective treatments within 10 years. Mission: Cure is working to make that happen. Consulting with pancreatic experts from the nation’s top research and healthcare institutions, we developed a 10-year plan and are working to implement it.


Financing Based On Patient Outcomes

a male scientist holds a pipette and puts liquid into small containers surroudned by beakers in a lab

Promising And Cost-Effective Methods To Cure Diseases

five business people sit around a laptop engaged in conversation

Active Collaboration Among Stakeholders

two people point and review a paper with bar and pie graphs

Partnerships With Impact Investors

The time is right to create a new model for curing disease.  Exciting developments in genetics and data are making precision medicine a reality. Healthcare payers are moving toward value-based funding, especially for chronic diseases.  And a new generation of impact investors—seeking to generate social and not just financial returns—have made curing disease a priority.


We cannot do this without your support.


News from Mission: Cure

April 20, 2022 in Mission: Cure Updates, News

Exciting Updates from Mission: Cure

Join our mailing list and the first to know about the newest breakthroughs in pancreatitis research and important patient-education events. Meet the New Face of Science at Mission: Cure Meet Lola Rahib, Ph.D. Lola recently joined Mission: Cure as vice president of translational research to move our “cure strategy” forward. Lola has a Ph.D. in biomedical engineering, expertise in pancreatic…
Read More
November 3, 2021 in News

Mission: Cure Selected to Join The Chan Zuckerberg Initiative’s Rare As One Network

October 4, 2018 | Carly Cheung, scientist at the Chan Zuckerberg Biohub in San Francisco, shows Sandra Chipuka and Ernestine Dada Johnson, TechWomen’s Emerging Leaders, tools used in the BSL-1 lab. | Photograph by CZI We are delighted to announce that Mission: Cure has been selected as one of 20 patient-led organizations to join the Rare As One Network. The…
Read More

Mission: Cure – Blog

April 25, 2022 in Genetics, Patient Resources, Uncategorized

Genetic Testing for Pancreatitis: A Toolkit

There are many benefits to getting genetic testing-- and it also comes with limitations. Genetic testing for pancreatitis might give you a fuller picture of your disease. Pancreatitis-specific genetic tests, like those provided by Ariel Precision Medicine, test for a number of gene mutations in your DNA, like CFTR, PRSS1, and SPINK1. These gene mutations are known to cause chronic…
Read More
April 25, 2022 in Genetics, Patient Resources

Genetic Testing Toolkit: What is Genetic Testing?

Genetic testing involves taking a closer look at your DNA. Just like your genes determine physical characteristics, like the color of your eyes or the color of your skin, your DNA might also give you clues about what's going on beneath the surface. It might give you clues about your health-- whether or not you are genetically predisposed to certain…
Read More

Mission: Cure – Twitter